How can we help?

To learn more about our services get in touch on +44 20 7246 7800 or sales@trustedsources.co.uk.

Recent China research

* China Watch: Resilience as headwinds are building, Michelle Lam, Trey McArver, Jon Harrison, 17 Aug 2017
* China Perspective - Korea, China, US: Edging towards Brink, Jonathan Fenby, 14 Aug 2017
* China Watch: Why the growth path will be bumpier after the Party Congress, Bo Zhuang, Jon Harrison, Trey McArver, 10 Aug 2017
* Korean crisis grows more dangerous, Jonathan Fenby, 9 Aug 2017
* China Watch: Corporate earnings recovery boosts sentiment, Bo Zhuang, Larry Brainard, Trey McArver, 3 Aug 2017

See all our China research >>

The openings in China’s pharmaceutical sector reform

Overview

China’s sheer size, ageing population, growing middle class and rapid economic development have all encouraged fantastic predictions about the potential of its healthcare and pharmaceutical markets. PricewaterhouseCoopers has forecast that China will become the world’s fifth biggest pharmaceutical market by 2010 and overtake the US as the top pharmaceutical market by 2050. Official statistics suggest total revenues of China’s pharmaceutical industry in 2006 were around US$64...

* Access to this publication is restricted

Request access

If you would like to read this publication, please enter your name and email address below:

Alternatively please call us on +44 20 7183 5280, or email sales@trustedsources.co.uk.

Already registered?